Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 5.320 | 52.760 | 47.440 |
Stocks | 94.680 | 95.420 | 0.740 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.787 | 14.362 |
Price to Book | 1.700 | 2.008 |
Price to Sales | 1.132 | 1.322 |
Price to Cash Flow | 6.584 | 8.695 |
Dividend Yield | 2.716 | 3.242 |
5 Years Earnings Growth | 8.995 | 9.671 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 25.270 | 14.876 |
Industrials | 22.470 | 15.809 |
Consumer Defensive | 11.690 | 11.585 |
Financial Services | 10.830 | 17.227 |
Consumer Cyclical | 9.330 | 10.588 |
Energy | 8.510 | 5.145 |
Technology | 6.790 | 9.527 |
Utilities | 5.110 | 4.483 |
Number of long holdings: 48
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 5.63 | 236.60 | +0.77% | |
TotalEnergies SE | FR0000120271 | 5.07 | 67.00 | +0.81% | |
Genmab | DK0010272202 | 4.94 | 2,035.0 | +0.44% | |
EDP | PTEDP0AM0009 | 4.88 | 3.810 | -1.96% | |
AstraZeneca | GB0009895292 | 4.73 | 12,132.0 | -0.28% | |
UBS Group | CH0244767585 | 4.35 | 27.51 | +0.33% | |
Lonza Group | CH0013841017 | 3.97 | 527.40 | 0.00% | |
EssilorLuxottica | FR0000121667 | 3.65 | 207.30 | +0.44% | |
SIG Group | CH0435377954 | 3.65 | 19.10 | -0.78% | |
London Stock Exchange | GB00B0SWJX34 | 3.57 | 9,278.0 | +0.52% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
IE00BRJT7H22 | 3.43B | 1.86 | 2.11 | - | ||
Man GLG Alpha Sel Alt DL H USD Acc | 1.73B | 1.34 | 7.49 | 6.54 | ||
Man GLG Euro MidCap Eq Alt DN H USD | 66.37M | -0.07 | -0.54 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review